Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.2%

24 terminated/withdrawn out of 292 trials

Success Rate

84.0%

-2.5% vs industry average

Late-Stage Pipeline

10%

28 trials in Phase 3/4

Results Transparency

11%

14 of 126 completed trials have results

Key Signals

37 recruiting14 with results17 terminated7 withdrawn

Enrollment Performance

Analytics

N/A

95(51.1%)

Phase 2

41(22.0%)

Phase 1

20(10.8%)

Phase 3

17(9.1%)

Phase 4

11(5.9%)

Early Phase 1

2(1.1%)

186Total

N/A(95)

Phase 2(41)

Phase 1(20)

Phase 3(17)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (292)

Showing 20 of 292 trials

NCT03049254Recruiting

Mayo AVC Registry and Biobank

Role: collaborator

NCT07538440Active Not Recruiting

Prognostic Model for Predicting Outcome After Moderate to Severe Paediatric Traumatic Brain Injury

Role: lead

NCT07002320Phase 1Recruiting

Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer

Role: collaborator

NCT05450484Phase 1Completed

Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer

Role: collaborator

NCT07516496Recruiting

Metabolic Phenotyping in vEDS

Role: lead

NCT05808543Not ApplicableRecruiting

BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants

Role: collaborator

NCT07496775Not Yet Recruiting

Cardiovascular Acoustics for Early Disease Detection

Role: lead

NCT07489898Not Yet Recruiting

Novel Technologies to Measure Vision-related Quality of Life

Role: collaborator

NCT07341230Not ApplicableRecruiting

Deep Brain Stimulation to Understand and Treat Addiction

Role: collaborator

NCT07483801Phase 4Not Yet Recruiting

DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies

Role: lead

NCT07201038Recruiting

Ultrafast Whole Genome Sequencing for Childhood Cancer

Role: collaborator

NCT07157735Phase 2Recruiting

A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease

Role: lead

NCT07391215Phase 1Recruiting

5G-PEARL: Paxalisib in Malignant Brain Tumours

Role: collaborator

NCT07364175Not ApplicableRecruiting

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Role: lead

NCT06630260Phase 1Recruiting

5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

Role: collaborator

NCT06584123Not ApplicableRecruiting

Molecular Pituitary Imaging Using 18F-FET PET

Role: collaborator

NCT05635409Phase 1Active Not Recruiting

A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease

Role: collaborator

NCT05131828Phase 2Completed

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Role: lead

NCT06733103Not ApplicableCompleted

Pilot of Cognitive Stimulation Therapy for Pre-frail Stroke Survivors

Role: collaborator

NCT06533007Enrolling By Invitation

PDE3B in Metabolic Regulation

Role: lead